Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Network meta-analysis models to account for variability in treatment definitions: application to dose effects.
Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination.
Cross Cultural Validation of The Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) and The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).
Effects of inoculation with attenuated autologous T cells in patients with rheumatoid arthritis.
Efficient transdifferentiation of human adipose-derived stem cells into Schwann-like cells: A promise for treatment of demyelinating diseases.
The impact of neutralizing antibodies on the risk of disease worsening in interferon β-treated relapsing multiple sclerosis: a 5 year post-marketing study.
Cognitive reserve and symptom experience in multiple sclerosis: A buffer to disability progression over time?
Modulation of alertness by sustained cognitive demand in MS as surrogate measure of fatigue and fatigability.
Developing a community multiple sclerosis nursing service.
The effects of aquatic therapy on mobility of individuals with neurological diseases: A systematic review.
Balò's concentric sclerosis: still to be considered as a variant of multiple sclerosis?
Curcuminoids in Neurodegenerative Diseases.
Co-occurrence of two cases of progressive multifocal leukoencephalopathy in a natalizumab "infusion group"
Imaging new lesions: Enhancing our understanding of multiple sclerosis pathogenesis.
Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota.
Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica.
OASIS is Automated Statistical Inference for Segmentation, with applications to multiple sclerosis lesion segmentation in MRI.
The life extension protein Klotho enhances remyelination following cuprizone-induced demyelination
Effects of non-steroidal antiinflammatory drugs on D-serine-induced oxidative stress in vitro.
[Damage of macular ganglion cell complex and peripapillary retinal nerve fiber layer in multiple sclerosis.]
Couples coping with multiple sclerosis: a dyadic perspective on the roles of mindfulness and acceptance.
Low dose zymosan ameliorates both chronic and relapsing experimental autoimmune encephalomyelitis.
Sphingolipids in ocular inflammation.
Fingolimod in active multiple sclerosis: an impressive decrease in Gd-enhancing lesions.
Regulation of Neuroinflammation through Programed Death-1/Programed Death Ligand Signaling in Neurological Disorders.
Pages
« first
‹ previous
…
238
239
240
241
242
243
244
245
246
…
next ›
last »